In an integrated audit of internal control over financial reporting and the financial statements, the auditor also may use this work to obtain evidence supporting the auditor's assessment of control risk for purposes of the audit of the financial statements.
A new development in uveitis treatment during the past few years is the increased use of tumor necrosis alpha (TNF-Î±) inhibitors, specifically infliximab (Remicade, Janssen Biotech Inc.) and adalimumab (Humira, Abbott Laboratories).
For Patients. Latisse (bimatoprost) Ophthalmic Solution is a synthetic prostaglandin analog used to treat patients with not enough or inadequate eyelashes. Latisse is also used to treat glaucoma. Common side effects of Latisse include eye redness or discomfort, eye itching, dry eyes, watery eyes, or eyelid redness, or puffy eyelids.